Market News AIOpen the app

CSTL stock news · Castle Biosciences

Stories about Castle Biosciences (CSTL) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CSTL

Follow Castle Biosciences (CSTL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CSTL
Free on the App Store and Google Play, or on the web.
  1. Nov 5, 2026, 5:28 PM ET · Market

    Castle Biosciences shared that its sales hit $102.9 million last quarter, up 24% from last year.

    Good for CSTL

    Castle Biosciences raised its 2026 revenue forecast to $385 million–$395 million after third-quarter revenue grew 24%. Faster test growth and the higher forecast make this positive.